Trial Details
COMPLETEDBasic Information
| Clinical ID | c3777 |
|---|---|
| Identifier | NCT01543178 |
| Trial Title | Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: open-label rifaximin|DRUG: double-blind placebo|DRUG: double-blind rifaximin |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Anniston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2012-02 |
|---|---|
| Primary Completion Date | 2014-06 |
| Completion Date | 2014-06 |